MedTrace Logo

Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case Series

NCT02335450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2021-06-02

Study results available
· View outcomes & findings →

Summary

This study evaluates the effectiveness of personalized physical activity coaching combined with the use of a physical activity monitor to support increased levels of daily physical activity in individuals with multiple sclerosis. All five participants will receive the intervention over the four week intervention phase.

Conditions

Interventions

BEHAVIORAL

Motivational Interviewing

The participant will describe their unique physical activity challenges and their physical activity goals with the physical therapist. Using the technique of motivational interviewing, the physical therapist will work with the participant to help identify potential solutions to challenges and set realistic activity goals for the next week. Each week, the participant and the physical therapist will review the previous week's activity data, and the participant's reports of any challenges or problems they encountered in meeting their physical activity goals the previous week. The participant will identify new activity goals for the next week.

DEVICE

Wristband physical activity monitor

The participant will wear a Fitbit wristband which will track the participant's daily steps and minutes of physical activity.

Sponsors & Collaborators

  • Oakland University

    lead OTHER

Principal Investigators

  • Beth Black, DSc · Oakland University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-12
Primary Completion
2015-11-12
Completion
2015-11-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335450 on ClinicalTrials.gov